sesamol has been researched along with Neuroblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| da Silva Navarro, SM; de Almeida, FJS; de Oliveira, MR; Luckachaki, MD | 1 |
| Chen, W; Dai, X; Guo, R; Jia, M; Liu, X; Liu, Z; Wang, Y; Xie, T; Yang, C; Yuan, T; Yun, D; Zhang, Y; Zhao, Y | 1 |
2 other study(ies) available for sesamol and Neuroblastoma
| Article | Year |
|---|---|
Sesamol prevents mitochondrial impairment and pro-inflammatory alterations in the human neuroblastoma SH-SY5Y cells: role for Nrf2.
Topics: Benzodioxoles; Cell Line, Tumor; Cell Survival; Humans; Hydrogen Peroxide; Mitochondria; Neuroblastoma; NF-E2-Related Factor 2; Phenols; Reactive Oxygen Species | 2022 |
Sesamol Attenuates Scopolamine-Induced Cholinergic Disorders, Neuroinflammation, and Cognitive Deficits in Mice.
Topics: Animals; Antioxidants; Cholinergic Agents; Cognition; Cognitive Dysfunction; Humans; Lignans; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Nerve Growth Factors; Neuroblastoma; Neurodegenerative Diseases; Neuroinflammatory Diseases; Neuroprotective Agents; Oxidative Stress; Scopolamine; Sesame Oil | 2022 |